Precisely, muscle‐specific SirT1 gain‐of‐function mice are resistant to the stroke‐induced muscle atrophy as evidenced by no changes in the muscle mass and the expression levels of Atrogin‐1 and MuRF‐1 genes. The gene discussed is TRIM63; the disease is stroke disorder.